Fluticasone tackles infection of airway

COPD and asthma drug fluticasone reduces disease exacerbations because it tackles airway infection, as well as inflammation, a study suggests.

Fluticasone is known to reduce inflammation in the lungs as well as the exacerbations that COPD patients frequently suffer. Researchers from the University of the Balearic Islands looked at whether it might also reduce the rate of infection with bacteria such as Streptococcus pneumoniae and Haemophilus influenzae. Such infections are often found in patients experiencing exacerbations.

Part of the cell surface of these bacteria binds to the platelet-activating factor receptor (PAFR) on the cells lining the airways and studies have shown that steroids, such as fluticasone, reduce expression of PAFR.

The researchers first demonstrated that fluticasone reduced PAFR expression in human airway epithelial cells. They then studied airway infections in mice and showed that fluticasone reduced invasion of the airway epithelial cells by S pneumoniae and H influenzae.

Further experiments showed that it was the drug's action on PAFR that causes this effect.

'These novel molecular effects can explain the reduction in the frequency of exacerbations observed in patients treated with fluticasone propionate,' the authors said.

tom.moberly@haymarket.com

Eur Respir J 2008; 32: 1,283-88

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

GPs to place orders for COVID-19 vaccine as NHS targets second dose at 12 weeks, says Stevens

GPs to place orders for COVID-19 vaccine as NHS targets second dose at 12 weeks, says Stevens

GP-led vaccination sites will be able to place orders for COVID-19 vaccine supplies...

RCGP and Marie Curie urge GPs to adopt end of life care standards for care homes

RCGP and Marie Curie urge GPs to adopt end of life care standards for care homes

Best practice standards to help GPs improve end of life care in care homes despite...

Thank your team for their inspirational work during the COVID-19 pandemic #myGPteam

Thank your team for their inspirational work during the COVID-19 pandemic #myGPteam

Never has teamwork in general practice been more important than during the COVID-19...

BMA mourns 'dark death toll' as UK passes 100,000 COVID-19 deaths

BMA mourns 'dark death toll' as UK passes 100,000 COVID-19 deaths

More than 100,000 people have now died from COVID-19 in the UK, five times the death...

Viewpoint: End-of-life care in care homes goes well beyond COVID-19

Viewpoint: End-of-life care in care homes goes well beyond COVID-19

Best practice standards for GPs and teams caring for older people in care homes -...